Abstract
Hyperuricemia, particularly gout, and the immune inflammatory response are highly integrated. Both, long standing hyperuricemia and monosodium urate (MSU) crystal deposition can challenge tendon homeostasis because of their potential to cause inflammation to the host. Knowledge is emerging from clinical imaging research depicting where MSU crystals deposit, including patellar tendon, triceps and quadriceps tendons. Remarkably, subclinical tendon inflammation and damage are also present in asymptomatic hyperuricemia. Monosodium urate crystals act as danger activating molecular patterns (DAMPs), activating the inflammasome and inducing the secretion of IL-1beta, a key mediator of the inflammatory response. The crucial role of IL-1beta in driving the inflammatory events during gout attacks is supported by the clinical efficacy of IL-1beta blockade. Some data implicating IL-1beta as an initiator of tendinopathy exist, but the link between hyperuricemia and the development of tendinopathy remains to be validated. Further knowledge about the interactions of uric acid with both innate immune and tendon cells, and their consequences may help to determine if there is a subclass of hyperuricemic-tendinopathy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ADAMTS1:
-
A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 1
- ADAMTS4:
-
A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 4
- ADAMTS5:
-
A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 5
- CRP:
-
C reactive protein
- DAMP:
-
Danger Associated Molecular patterns
- DECT:
-
dual energy computerized tomography
- DNA:
-
deoxynucleic acid
- IL-1beta, IL-1alpha, IL-6, IL-8, IL-18:
-
Interleukins
- MCP-1/CCL2:
-
macrophage chemotactic protein
- MMP-2, MMP-3, MMP-13:
-
metalloproteinases
- MSU:
-
monosodium urate
- NLRP3:
-
NOD-like receptor protein 3
- NSAIDs:
-
non-steroidal anti-inflammatory drugs
- PGE2:
-
prostaglandin E2
- RNA:
-
ribonucleic acid
- TLR2, TLR4:
-
Toll like receptors
- TNF-alpha:
-
tumor necrosis factor alpha
- VEGF:
-
vascular endothelial growth factor
References
Abate M, Schiavone C, Salini V, Andia I (2013) Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford) 52(4):599–608
Ackermann PW, Domeij-Arverud E, Leclerc P, Amoudrouz P, Nader GA (2013) Anti-inflammatory cytokine profile in early human tendon repair. Knee Surg Sports Traumatol Arthrosc 21(8):1801–1806
Alfredson H (2005) The chronic painful Achilles and patellar tendon: research on basic biology and treatment. Scand J Med Sci Sports 15(4):252–259
Andia I, Sanchez M, Maffulli N (2010) Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther 10(10):1415–1426
Andia I, Rubio-Azpeitia E, Maffulli N (2014) Hyperuricemic PRP in tendon cells. Biomed Res Int 2014:926481
Andia I, Rubio-Azpeitia E (2014) Angiogenic and innate immune responses triggered by PRP in tendon cells are not modified by hyperuricemia. Muscles Ligaments Tendons J 4(3):292–297
Andia I, Rubio-Azpeitia E, Maffulli N (2015) Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res 473(5):1624–1634
Aslam N, Lo S, McNab I (2004) Gouty flexor tenosynovitis mimicking infection: a case report emphasising the value of ultrasound in diagnosis. Acta Orthop Belg 70(4):368–370
Bond JR, Sim FH, Sundaram M (2004) Radiologic case study. Gouty tophus involving the distal quadriceps tendon. Orthopedics 27(1):18, 90–92
Bullocks JM, Downey CR, Gibler DP, Netscher DT (2009) Crystal deposition disease masquerading as proliferative tenosynovitis and its associated sequelae. Ann Plast Surg 62(2):128–133
Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med 82(3):421–426
Chen CK, Chung CB, Yeh L, Pan HB, Yang CF, Lai PH, Liang HL, Resnick D (2000) Carpal tunnel syndrome caused by tophaceous gout: CT and MR imaging features in 20 patients. AJR Am J Roentgenol 175(3):655–659
Chhana A, Callon KE, Pool B, Naot D, Watson M, Gamble GD, McQueen FM, Cornish J, Dalbeth N (2011) Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout. Ann Rheum Dis 70(9):1684–1691
Chhana A, Callon KE, Dray M, Pool B, Naot D, Gamble GD, Coleman B, McCarthy G, McQueen FM, Cornish J, Dalbeth N (2014) Interactions between tenocytes and monosodium urate monohydrate crystals: implications for tendon involvement in gout. Ann Rheum Dis 73(9):1737–1741
Dalbeth N, Kalluru R, Aati O, Horne A, Doyle AJ, McQueen FM (2013) Tendon involvement in the feet of patients with gout: a dual-energy CT study. Ann Rheum Dis 72(9):1545–1548
de Mos M, Joosten LA, Oppers-Walgreen B, van Schie JT, Jahr H, van Osch GJ, Verhaar JA (2009) Tendon degeneration is not mediated by regulation of Toll-like receptors 2 and 4 in human tenocytes. J Orthop Res 27(8):1043–1047
Fredberg U, Stengaard-Pedersen K (2008) Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports 18(1):3–15
Fedorczyk JM, Barr AE, Rani S, Gao HG, Amin M, Amin S, Litvin J, Barbe MF (2010) Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J Orthop Res 28(3):298–307
Forbess LJ, Fields TR (2012) The broad spectrum of urate crystal deposition: unusual presentations of gouty tophi. Semin Arthritis Rheum 42(2):146–154
Gililland JM, Webber NP, Jones KB, Randall RL, Aoki SK (2011) Intratendinous tophaceous gout imitating patellar tendonitis in an athletic man. Orthopedics 34(3):223
Grainger R, McLaughlin RJ, Harrison AA, Harper JL (2013) Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Rheumatology (Oxford) 52(6):1018–1021
Gunawardena H, Churn P, Blake DR (2005) Running for gout research. Rheumatology (Oxford) 44(8):1073–1074
Kanevets U, Sharma K, Dresser K (2009) Shi Y A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity. J Immunol 182(4):1912–1918
Kimura-Hayama E, Criales-Vera S, Nicolaou S, Betanzos JL, Rivera Y, Alberú J, Rull-Gabayet M, Hernández-Molina G (2014) A pilot study on dual-energy computed tomography for detection of urate deposits in renal transplant patients with asymptomatic hyperuricemia. J Clin Rheumatol 20(6):306–309
Krishnan E, Lessov-Schlaggar CN, Krasnow RE, Swan GE (2012) Nature versus nurture in gout: a twin study. Am J Med 125(5):499–504
Kuo YL, Hsu CC, Kuo LC, Wu PT, Shao CJ, Wu KC, Wu TT, Jou IM (2015) Inflammation is present in de quervain disease–correlation study between biochemical and histopathological evaluation. Ann Plast Surg 74(Suppl 2):S146–S151
Kutzing MK, Firestein BL (2008) Altered uric acid levels and disease states. J Pharmacol Exp Ther 324(1):1–7
Lagoutaris ED, Adams HB, DiDomenico LA, Rothenberg RJ (2005) Longitudinal tears of both peroneal tendons associated with tophaceous gouty infiltration. A case report. J Foot Ankle Surg 44(3):222–224, Muscles Ligaments Tendons J. 2014 Nov 17;4(3):292–297
Legerlotz K, Jones ER, Screen HR, Riley GP (2012) Increased expression of IL-6 family members in tendon pathology. Rheumatology (Oxford) 51(7):1161–1165
Lian Ø, Scott A, Engebretsen L, Bahr R, Duronio V, Khan K (2007) Excessive apoptosis in patellar tendinopathy in athletes. Am J Sports Med 35(4):605–611
Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R (2005) TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 174(8):5016–5023
Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R (2005) Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 52(9):2936–2946
Martin WJ, Grainger R, Harrison A, Harper JL (2010) Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival. J Rheumatol 37(6):1228–1235
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237–241
Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Chiba T, Takahashi A, Nakamura T, Nakashima H, Takada Y, Danjoh I, Shimizu S, Abe J, Kawamura Y, Terashige S, Ogata H, Tatsukawa S, Yin G, Okada R, Morita E, Naito M, Tokumasu A, Onoue H, Iwaya K, Ito T, Takada T, Inoue K, Kato Y, Nakamura Y, Sakurai Y, Suzuki H, Kanai Y, Hosoya T, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N (2015) Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. Ann Rheum Dis 75(4):652–659. pii: annrheumdis-2014-206191
McCarty DJ (1994) Gout without hyperuricemia. JAMA 271(4):302–303
Melloni P, Valls R, Yuguero M, Sáez A (2004) An unusual case of tophaceous gout involving the anterior cruciate ligament. Arthroscopy 20(9):e117–e121
Millar NL, Wei AQ, Molloy TJ, Bonar F, Murrell GA (2009) Cytokines and apoptosis in supraspinatus tendinopathy. J Bone Joint Surg (Br) 91(3):417–424
Millar NL, Murrell GA, McInnes IB (2013) Alarmins in tendinopathy: unravelling new mechanisms in a common disease. Rheumatology (Oxford) 52(5):769–779
Mitha E, Schumacher HR, Fouche L, Luo SF, Weinstein SP, Yancopoulos GD, Wang J, King-Davis S, Evans RR (2013) Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial. Rheumatology (Oxford) 52(7):1285–1292
Naredo E, Uson J, Jiménez-Palop M, Martínez A, Vicente E, Brito E, Rodríguez A, Cornejo FJ, Castañeda S, Martínez MJ, Sanz J, Möller I, Batlle-Gualda E, Garrido J, Pascual E (2014) Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout? Ann Rheum Dis 73(8):1522–1528
Nirschl RP, Ashman ES (2003) Elbow tendinopathy: tennis elbow. Clin Sports Med 22(4):813–836
Pearce CJ, Ismail M, Calder JD (2009) Is apoptosis the cause of noninsertional achilles tendinopathy? Am J Sports Med 37(12):2440–2444
Perez-Ruiz F, Dalbeth N, Bardin T (2015) A review of uric acid, crystal deposition disease, and gout. Adv Ther 32(1):31–41
Pineda C, Amezcua-Guerra LM, Solano C, Rodriguez-Henríquez P, Hernández-Díaz C, Vargas A, Hofmann F, Gutiérrez M (2011) Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 13(1):R4
Pingel J, Wienecke J, Kongsgaard M, Behzad H, Abraham T, Langberg H, Scott A (2013) Increased mast cell numbers in a calcaneal tendon overuse model. Scand J Med Sci Sports 23(6):e353–e360
Puig JG, de Miguel E, Castillo MC, Rocha AL, Martínez MA, Torres RJ (2008) Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 27(6):592–595
Radice F, Monckeberg JE, Carcuro G (2011) Longitudinal tears of peroneus longus and brevis tendons: a gouty infiltration. J Foot Ankle Surg 50(6):751–753
Rock KL, Kataoka H, Lai JJ (2013) Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 9(1):13–23
Rodas G, Pedret C, Català J, Soler R, Orozco L, Cusi M (2013) Intratendinous gouty tophus mimics patellar tendonitis in an athlete. J Clin Ultrasound 41(3):178–182
Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27(10):1174–1181
Scharpf RB, Mireles L, Yang Q, Köttgen A, Ruczinski I, Susztak K, Halper-Stromberg E, Tin A, Cristiano S, Chakravarti A, Boerwinkle E, Fox CS, Coresh J, Linda Kao WH (2014) Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations. BMC Genet 15:81
Scott A, Lian Ø, Bahr R, Hart DA, Duronio V, Khan KM (2008) Increased mast cell numbers in human patellar tendinosis: correlation with symptom duration and vascular hyperplasia. Br J Sports Med 42(9):753–757
Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R (2006) Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 177(9):6370–6378
Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425(6957):516–521
Shields GE, Beard SM (2015) A systematic review of the economic and humanistic burden of gout. Pharmacoeconomics 33(10):1029–1047
Thampatty BP, Li H, Im HJ, Wang JH (2007) EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment. Gene 386(1–2):154–161
Wen CC, Yee SW, Liang X, Hoffmann TJ, Kvale MN, Banda Y, Jorgenson E, Schaefer C, Risch N, Giacomini KM (2015) Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Clin Pharmacol Ther 97(5):518–525
Yuan J, Murrell GA, Wei AQ, Wang MX (2002) Apoptosis in rotator cuff tendonopathy. J Orthop Res 20(6):1372–1379
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Andia, I., Abate, M. (2016). Hyperuricemia in Tendons. In: Ackermann, P., Hart, D. (eds) Metabolic Influences on Risk for Tendon Disorders. Advances in Experimental Medicine and Biology, vol 920. Springer, Cham. https://doi.org/10.1007/978-3-319-33943-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-33943-6_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33941-2
Online ISBN: 978-3-319-33943-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)